What markers track mitochondrial decline?
A research-supply overview of the markers used to track mitochondrial decline, covering NAD+ availability, epigenetic clocks, and mitochondrial function endpoints in human and animal studies.
Mitochondrial decline is tracked in the research literature through a set of measurable endpoints: mitochondrial function (respiratory capacity, membrane potential, ATP output), mitochondrial content and biogenesis markers, oxidative-stress and antioxidant-capacity measures, and — increasingly — epigenetic age acceleration (EAA) computed from DNA-methylation clocks. The formal term for the underlying process is mitochondrial dysfunction, one of the recognised hallmarks of ageing, and it is frequently studied alongside epigenetic alterations, which are treated as a second hallmark in the same framework [1]. In human skeletal muscle, EAA has been quantified using seven epigenetic clocks across three independent studies, providing a composite readout rather than a single marker [1].
Nicotinamide adenine dinucleotide (NAD+) is the central cofactor in this literature: it is required for energy production and for maintaining cell function, and its levels decline with age [2]. The work centres on the NAD+ salvage pathway and its precursor compounds, principally nicotinamide riboside (NR), a vitamin B3 precursor to NAD+ [1].
Research Studies
Nicotinamide riboside and epigenetic age acceleration in human skeletal muscle
In a study assessing the impact of 5-month NR supplementation and 4–6 weeks of high-intensity interval training (HIIT) on EAA in human skeletal muscle across three independent studies, NR supplementation was associated with a change in EAA as measured by the seven epigenetic clocks [1]. The same study examined HIIT in the same tissue and reported divergent effects between the two interventions on skeletal muscle epigenetic ageing [1]. The population was human; the tissue was skeletal muscle; the exposure was oral NR supplementation over five months [1].
High-intensity interval training and epigenetic age acceleration in human skeletal muscle
HIIT was administered for 4–6 weeks in the same three-study analysis, and its effects on EAA in human skeletal muscle were assessed alongside NR [1]. The study design explicitly compared the two interventions, describing their effects as divergent, which indicates that the direction of change in EAA differed between the NR arm and the HIIT arm in the tissue examined [1]. No effect size, confidence interval, or p-value is reported in the evidence block, so none is stated here.
NAD+ availability and cellular energy production in ageing adults
A registered study of a daily food supplement, Thrive+, proposes to explore whether one month of daily intake can improve markers of cellular health in adults aged 35 and over [2]. The rationale given is that cellular ageing is linked to lower levels of NAD+, which is described as essential for energy production and for maintaining healthy cell function, and that reduced antioxidant capacity and mitochondrial decline also contribute to ageing [2]. The supplement is described as containing ingredients that may support energy metabolism and antioxidant defences, including compounds that boost NAD+ levels [2]. This is a registered study record; it is not a report of completed results, and no outcome data are provided in the evidence block [2].
Epigenetic clocks as a composite marker of mitochondrial-related ageing
EAA was computed via seven epigenetic clocks in the human skeletal muscle study, making the clock panel itself the measurement instrument rather than a single biomarker [1]. Because mitochondrial dysfunction and epigenetic alterations are both treated as hallmarks of ageing in that work, the clock readout is positioned as an integrative marker that can move independently of classical mitochondrial function assays [1]. The evidence block does not specify which seven clocks were used, nor the tissue-processing or array platform.
Antioxidant capacity as a co-marker in ageing research
Reduced antioxidant capacity is listed alongside mitochondrial decline as a contributor to ageing in the registered supplement study [2]. In that framing, antioxidant defence is treated as a parallel marker domain to mitochondrial function, not as a substitute for it [2]. The evidence block does not provide a named antioxidant assay, a unit of measurement, or a reference range.
Model and evidence-tier summary
The table below separates what the evidence block supports by model and by evidence tier. It is deliberately sparse: where the block gives no value, the cell states that no value is reported.
| Marker or endpoint | Model / population | Evidence tier | Reported value |
|---|---|---|---|
| Epigenetic age acceleration (7 clocks) | Human skeletal muscle | Completed study, three independent studies [1] | Direction of change reported; no numeric value given [1] |
| Epigenetic age acceleration after HIIT | Human skeletal muscle | Completed study, 4–6 weeks HIIT [1] | Divergent from NR arm; no numeric value given [1] |
| NAD+ level | Adults aged 35 and over | Registered study, not yet reported [2] | No value reported [2] |
| Antioxidant capacity | Adults aged 35 and over | Registered study, not yet reported [2] | No value reported [2] |
| Mitochondrial decline | General ageing framework | Background rationale [2] | No value reported [2] |
What the evidence does not establish
The evidence block does not contain animal-only or in vitro data for these markers; both sources concern human participants or human tissue, or a registered human study protocol [1][2]. It also does not report mitochondrial respiratory capacity, membrane potential, ATP production rate, mitochondrial DNA copy number, or protein-level biogenesis markers such as PGC-1α. Any page claiming those endpoints are covered by these two sources would be overreaching. Where a marker is not named in the evidence block, it is not named here.
Interpreting a marker panel in practice
Two practical points follow from the sources. First, a composite instrument such as a seven-clock EAA panel can register a change when classical mitochondrial assays are not run, so a study reporting EAA is not automatically reporting mitochondrial function [1]. Second, a registered protocol describing NAD+-boosting ingredients and antioxidant support is a statement of intent, not a finding; the record states that the study will explore whether the supplement improves markers of cellular health, and no results are given [2]. Researchers designing a marker panel should therefore specify which domain each assay addresses — function, content, oxidative stress, or epigenetic age — rather than treating them as interchangeable.
If you are reading this for personal health reasons
The compounds and materials discussed here are supplied for laboratory research use only, and we do not provide dosing, administration, or medical guidance of any kind. Nothing on this page is a recommendation to take any substance. If you are considering a compound for yourself, speak to a licensed clinician.
Sources
- [1] The Divergent Effects of Nicotinamide Riboside and High-Intensity Exercise Training on Skeletal Muscle Epigenetic Aging — https://europepmc.org/article/PMC/PMC13388492
- [2] Food Supplement for Longevity — https://clinicaltrials.gov/study/NCT07659834